Cargando…
The COVID-19 exit strategy—why we need to aim low
Autor principal: | The Lancet Infectious Diseases |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7906683/ https://www.ncbi.nlm.nih.gov/pubmed/33581748 http://dx.doi.org/10.1016/S1473-3099(21)00080-3 |
Ejemplares similares
-
Unmet need for COVID-19 therapies in community settings
por: The Lancet Infectious Diseases
Publicado: (2021) -
Why hybrid immunity is so triggering
por: The Lancet Infectious Diseases
Publicado: (2022) -
Should we vaccinate children against SARS-CoV-2?
por: The Lancet Infectious Diseases
Publicado: (2021) -
Need for global cooperation in control of MERS-CoV
por: The Lancet Infectious Diseases
Publicado: (2013) -
The COVID-19 infodemic
por: The Lancet Infectious Diseases
Publicado: (2020)